Skip to content

Study on early warning of cerebral infarction risk and intervention mechanism of ''Xing-Nao Kai-Qiao'' acupuncture method

Study on early warning of cerebral infarction risk and intervention mechanism of ''Xing-Nao Kai-Qiao'' acupuncture method

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004937
Enrollment
Unknown
Registered
2021-06-10
Start date
2021-06-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral infarction

Interventions

Experimental group:acupuncture

Sponsors

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 40 to 80 years; 2.The first onset of acute ischemic stroke patients, or have a history of ischemic stroke, but the National Institute of Health Stroke Scale (NIHSS) is less than 4 points, and within 48 hours of onset, through history, physical examination, CT or MRI examination confirmed the existence of acute ischemic stroke; 3.The patients agreed to accept the protocol and signed the informed consent; 4.Patients can cooperate with the collection and preservation of medical history data and the follow-up process in the future.

Exclusion criteria

Exclusion criteria: 1. Patients with needle sickness; 2. Patients with history of intracranial hemorrhage or subarachnoid hemorrhage; 3. Atrial fibrillation and other cardiogenic acute ischemic stroke patients; 4. End stage patients with severe disability or disease; 5. There were severe heart, liver and kidney dysfunction, total bilirubin > 1.5 times of the upper limit of normal value, aspartate aminotransferase (AST) or alanine aminotransferase (ALT) > 2.5 times of the upper limit of normal value; 6. Patients with pulmonary infection or severe systemic infection; 7. Other brain organic diseases cause intracranial hypertension, such as brain tumors; 8. Patients with HIV positive, syphilis antibody positive, hepatitis B, hepatitis C or other serious infectious diseases; 9. Patients with severe mental illness, cognitive impairment or inability to understand and sign informed consent; 10. Patients with metabolic diseases such as diabetes, hyperthyroidism or hypothyroidism, gout, etc; 11. Patients who participated in other clinical studies within 3 months; 12. Patients who have experienced surgery or trauma (including fracture) in the past month.

Design outcomes

Primary

MeasureTime frame
National Institutes of Health Stroke Scale;Metabolomics detection;

Secondary

MeasureTime frame
Efficacy criteria;Barthel index of activities of daily living;Modified Rankin scale;

Countries

China

Contacts

Public ContactLi Jing

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

1725155193@qq.com+86 18920351627

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026